Gallagher Duncan (CIK 1780880) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-19). Recent activity: Buy HCAT (7,562 shares), Buy HCAT (6,209 shares), Buy HCAT (4,970 shares), Buy HCAT (36,231 shares), Buy HCAT (4,080 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-19 | Health Catalyst, Inc. (HCAT) | Director | Buy | 7,562 | $0 |
| 2025-12-03 | Health Catalyst, Inc. (HCAT) | Director | Buy | 6,209 | $0 |
| 2025-09-05 | Health Catalyst, Inc. (HCAT) | Director | Buy | 4,970 | $0 |
| 2025-07-10 | Health Catalyst, Inc. (HCAT) | Director | Buy | 36,231 | $0 |
| 2025-06-03 | Health Catalyst, Inc. (HCAT) | Director | Buy | 4,080 | $0 |
| 2025-03-04 | Health Catalyst, Inc. (HCAT) | Director | Buy | 3,033 | $0 |
Source: SEC Form 4 filings · as of 2026-02-19